We are live on !
Find out more
Wealth Effects Portfolio holdings
AUM
$370M
Turnover
11.85%
1-Year Est. Return
63.53%
This Fund
S&P 500
This Quarter Est. Return
-19.17%
1 Year Est. Return
+63.53%
3 Year Est. Return
+235.33%
5 Year Est. Return
+296.22%
10 Year Est. Return
–
AUM
$166M
AUM Growth
-$48.1M
(-22%)
Cap. Flow
+$1.67M
Cap. Flow % of AUM
Cap. Flow %
1.01%
Top 10 Holdings %
Top 10 Hldgs %
35.36%
Holding
217
New
13
Increased
89
Reduced
57
Closed
28
Avg Time Held
0.5
years
Top 10 Avg Time Held
0.4
years
Top 20 Avg Time Held
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
indie Semiconductor
INDI
|
+$1.41M |
| 2 |
Organon & Co
OGN
|
+$1.09M |
| 3 |
Apple
AAPL
|
+$964K |
| 4 |
AVDL
Avadel Pharmaceuticals
AVDL
|
+$849K |
| 5 |
VanEck Agribusiness ETF
MOO
|
+$362K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teladoc Health
TDOC
|
+$1.22M |
| 2 |
Adobe
ADBE
|
+$507K |
| 3 |
Citigroup
C
|
+$447K |
| 4 |
Meta Platforms (Facebook)
META
|
+$436K |
| 5 |
Block Inc
XYZ
|
+$408K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.35% |
| 2 | Healthcare | 23.78% |
| 3 | Miscellaneous | 13.08% |
| 4 | Financials | 9.68% |
| 5 | Communication Services | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Apple
AAPL
$5.07T
| $15.6M | 9.4% |
114,211
+6,368
| +6% | +$964K |
2021 Q4
2 quarters
|
|
2
Amazon
AMZN
$2.68T
| $6.44M | 3.88% |
60,681
+2,061
| +4% | +$258K |
2021 Q4
2 quarters
|
|
|
AVDL
3
DELISTED
Avadel Pharmaceuticals
AVDL
| $6.3M | 3.79% |
2,584,090
+206,800
| +9% | +$849K |
2021 Q4
2 quarters
|
|
4
Microsoft
MSFT
$3.89T
| $5.53M | 3.33% |
21,521
+1,104
| +5% | +$300K |
2021 Q4
2 quarters
|
|
5
Arrowhead Research
ARWR
$8.2B
| $5.41M | 3.26% |
153,620
+3,400
| +2% | +$128K |
2021 Q4
2 quarters
|
|
6
NVIDIA
NVDA
$5.09T
| $4.19M | 2.52% |
276,310
-4,050
| -1% | -$76.4K |
2021 Q4
2 quarters
|
|
7
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.49B
| $3.91M | 2.35% |
80,881
+756
| +0.9% | +$36.7K |
2021 Q4
2 quarters
|
|
8
Alphabet (Google) Class A
GOOGL
$3.92T
| $3.88M | 2.34% |
35,620
-20
| -0.1% | -$2.36K |
2021 Q4
2 quarters
|
|
9
Pfizer
PFE
$171B
| $3.86M | 2.32% |
73,580
+3,198
| +5% | +$163K |
2021 Q4
2 quarters
|
|
10
JPMorgan Chase
JPM
$881B
| $3.62M | 2.18% |
32,143
+396
| +1% | +$49.1K |
2021 Q4
2 quarters
|
|
11
Blackstone
BX
$94.1B
| $3.34M | 2.01% |
36,617
+508
| +1% | +$54.9K |
2021 Q4
2 quarters
|
|
12
3D Systems Corp
DDD
$505M
| $2.59M | 1.56% |
266,925
+650
| +0.2% | +$7.59K |
2021 Q4
2 quarters
|
|
13
Chevron
CVX
$457B
| $2.35M | 1.41% |
16,227
+121
| +0.8% | +$20K |
2021 Q4
2 quarters
|
|
14
Trade Desk
TTD
$6.15B
| $2.26M | 1.36% |
53,875
-4,950
| -8% | -$271K |
2021 Q4
2 quarters
|
|
15
Beyond Air
XAIR
$2.06M
| $2.19M | 1.32% |
820
+84
| +11% | +$203K |
2021 Q4
2 quarters
|
|
16
AbbVie
ABBV
$505B
| $2.18M | 1.31% |
14,238
+491
| +4% | +$75K |
2021 Q4
2 quarters
|
|
17
Steris
STE
$22.6B
| $2.17M | 1.31% |
10,543
-33
| -0.3% | -$7.44K |
2021 Q4
2 quarters
|
|
18
CVS Health
CVS
$120B
| $1.94M | 1.16% |
20,887
+101
| +0.5% | +$9.9K |
2021 Q4
2 quarters
|
|
19
UnitedHealth
UNH
$375B
| $1.86M | 1.12% |
3,627
+255
| +8% | +$128K |
2021 Q4
2 quarters
|
|
20
Johnson & Johnson
JNJ
$635B
| $1.86M | 1.12% |
10,489
+282
| +3% | +$50.2K |
2021 Q4
2 quarters
|
|
21
Roku
ROKU
$23.6B
| $1.85M | 1.11% |
22,494
+2,350
| +12% | +$228K |
2021 Q4
2 quarters
|
|
22
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.28B
| $1.74M | 1.05% |
99,440
+7,960
| +9% | +$150K |
2021 Q4
2 quarters
|
|
23
American Tower
AMT
$88.1B
| $1.58M | 0.95% |
6,192
-75
| -1% | -$18.8K |
2021 Q4
2 quarters
|
|
24
Bank of America
BAC
$350B
| $1.56M | 0.94% |
50,053
-1,163
| -2% | -$41.9K |
2021 Q4
2 quarters
|
|
25
Merck
MRK
$358B
| $1.5M | 0.91% |
16,500
+118
| +0.7% | +$10.5K |
2021 Q4
2 quarters
|
|
Similar funds
BC
MLCM
Wealth Effects's Q2 2022 Portfolio in Review
As of Q2 2022, Wealth Effects held 217 positions worth $166M, down 22% from $214M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Wealth Effects's Q2 2022 filing shows 13 new, 89 increased, 57 reduced and 28 closed positions. Its largest new stake was indie Semiconductor: 204,951 shares worth $1.17M. The largest sale was Teladoc Health, an estimated $1.22M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Miscellaneous.
- Wealth Effects's largest Q2 2022 buy was indie Semiconductor: 204,951 shares worth $1.17M.
- Wealth Effects added most to Apple in Q2 2022, an estimated $964K increase.
- Wealth Effects's biggest Q2 2022 reduction was Walt Disney, cutting an estimated $298K.
- Wealth Effects fully exited Teladoc Health in Q2 2022, selling an estimated $1.22M.
- Wealth Effects's ten largest holdings make up 35% of its $166M portfolio in Q2 2022.
- Wealth Effects opened 13 new positions and closed 28 in Q2 2022.
- Wealth Effects's portfolio value fell 22% quarter-over-quarter to $166M.
Based on Wealth Effects's 13F filing for Q2 2022, filed 3 Aug 2022.